Table of Contents
Introduction: Three Approaches to Brain Enhancement
Selank, Semax, and Dihexa represent three distinct strategies for cognitive and neuroprotective research. Selank calms the brain (anxiolytic via GABA/enkephalin modulation). Semax sharpens the brain (nootropic via BDNF/neurotransmitter enhancement). Dihexa rewires the brain (synaptogenic via HGF/c-Met neurotrophic signaling at picomolar potency).
Each targets a different bottleneck in brain function: anxiety interference, neurotrophic signaling, or synaptic connectivity.
Three-Way Comparison Overview
| Feature | Selank | Semax | Dihexa |
|---|---|---|---|
| Type | Tuftsin analog | ACTH(4-10) analog | AngIV peptidomimetic |
| Primary Effect | Anxiolytic | Nootropic | Synaptogenic |
| Key Mechanism | GABA modulation + enkephalin preservation | BDNF upregulation + monoamine modulation | HGF/c-Met ? spine/synapse formation |
| Potency | Standard (?g range) | Standard (?g range) | Ultra-high (picomolar) |
| Route | Intranasal | Intranasal | Oral / injectable |
| Clinical Status | Approved in Russia | Approved in Russia | Preclinical only |
| Safety Data | Extensive (clinical use) | Extensive (clinical use) | Very limited |
| Addiction Risk | None (non-benzo mechanism) | None | None known |
Selank: The Anxiolytic Nootropic
Selank reduces anxiety through indirect GABA enhancement and enkephalin degradation inhibition. It also upregulates BDNF and modulates IL-6 expression. Ideal for research where anxiety interferes with cognitive testing or where anxiolytic effects without sedation are needed. Approved in Russia.
Semax: The Cognitive Enhancer
Semax enhances learning, memory, and attention through BDNF upregulation and monoamine modulation. It is the most directly nootropic of the three, with demonstrated improvements in spatial memory tasks and clinical stroke recovery data. Approved in Russia.
Dihexa: The Synaptogenic Powerhouse
Dihexa creates new synaptic connections by potentiating HGF/c-Met signaling at picomolar concentrations. It represents the most dramatic cognitive restoration in preclinical models — aged rats returned to young-animal learning levels (PMID: 23055539). However, safety data is very limited, and its extreme potency requires precise dosing.
Application Comparison
| Research Focus | Best Choice | Why |
|---|---|---|
| Anxiety + cognition | Selank | Only anxiolytic of the three |
| Learning and memory | Semax | Direct BDNF + clinical data |
| Stroke recovery | Semax | Approved indication in Russia |
| Age-related cognitive decline | Dihexa | Restores aged cognition to young levels |
| Synaptogenesis research | Dihexa | Direct spine/synapse formation |
| Safety-conscious protocols | Selank or Semax | Clinical approval, extensive safety data |
Choosing the Right Peptide
Choose Selank when: Anxiety is the primary research variable, or non-sedating anxiolysis is needed alongside cognitive testing. Also for immune-neuro interactions (tuftsin-derived immunomodulation).
Choose Semax when: Pure cognitive enhancement — learning, memory, attention — is the endpoint. Also for stroke recovery models, BDNF biology, and research requiring clinical precedent.
Choose Dihexa when: Age-related cognitive decline and synaptogenesis are the specific research questions. Use with extreme dose caution due to picomolar potency and limited safety data.
Frequently Asked Questions
Which nootropic peptide is the strongest?
In terms of potency, Dihexa is active at picomolar concentrations — orders of magnitude more potent than Selank or Semax. In terms of clinical evidence, Semax has the strongest backing with Russian clinical approval. “Strongest” depends on whether you mean most potent (Dihexa), most evidence-backed (Semax), or most anxiolytic (Selank).
Can all three be combined?
They target non-overlapping pathways (GABA/enkephalin, BDNF/monoamines, HGF/c-Met), so receptor competition is not a concern. A triple combination would address anxiety (Selank), cognitive signaling (Semax), and synaptic structure (Dihexa) simultaneously. However, Dihexa’s limited safety data makes any combination involving it experimental and requiring extreme caution.
Are Selank and Semax related?
Yes — they were both developed at the same Russian research institute (Institute of Molecular Genetics, Russian Academy of Sciences) and share some mechanisms (BDNF upregulation). However, they are derived from different parent molecules: Selank from tuftsin (an immunopeptide) and Semax from ACTH(4-10) (a neuroendocrine fragment). Their primary indications differ: Selank for anxiety, Semax for cognition.
References
- Dolotov OV, et al. Semax regulates BDNF and trkB expression in the rat hippocampus. Brain Res. 2006;1117(1):54-60.
- Kozlovskii II, et al. The role of the GABA-ergic system in Selank’s mechanism. Bull Exp Biol Med. 2002;134(2):168-170.
- McCoy AT, et al. Evaluation of Dihexa as procognitive/antidementia agent. J Pharmacol Exp Ther. 2013;344(1):141-154. PMID: 23055539
About Proxiva Labs: We supply Semax for nootropic research. For neuroprotective healing, see BPC-157. Browse the complete research peptide catalog.
All products are sold strictly for research purposes only. Not for human consumption.